Ingevity Corp Enters Material Definitive Agreement

Ticker: NGVT · Form: 8-K · Filed: 2025-03-31T00:00:00.000Z

Sentiment: neutral

Topics: material-definitive-agreement, filing-update

TL;DR

Ingevity Corp just signed a big deal, filing an 8-K on March 30, 2025.

AI Summary

On March 30, 2025, Ingevity Corporation entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company is incorporated in Delaware and headquartered in North Charleston, South Carolina.

Why It Matters

This filing indicates a significant new contract or partnership for Ingevity Corporation, which could impact its future revenue and operations.

Risk Assessment

Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities that are not yet fully understood.

Key Numbers

Key Players & Entities

FAQ

What type of material definitive agreement did Ingevity Corporation enter into?

The filing states that Ingevity Corporation entered into a 'Material Definitive Agreement' but does not specify the exact nature of the agreement in the provided text.

What is the significance of the filing date?

The filing date of March 30, 2025, indicates the date of the report and the earliest event reported, which is the entry into the material definitive agreement.

Where is Ingevity Corporation's principal executive office located?

Ingevity Corporation's principal executive offices are located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.

What is Ingevity Corporation's fiscal year end?

Ingevity Corporation's fiscal year ends on December 31st.

What is the SEC file number for Ingevity Corporation?

The SEC file number for Ingevity Corporation is 001-37586.

From the Filing

0001140361-25-011158.txt : 20250331 0001140361-25-011158.hdr.sgml : 20250331 20250331070022 ACCESSION NUMBER: 0001140361-25-011158 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250330 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25788790 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 8-K 1 ef20046464_8k.htm 8-K false 0001653477 0001653477 2025-03-30 2025-03-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2025 Date of Report (date of earliest event reported) INGEVITY CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37586 47-4027764 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 4920 O’Hear Avenue Suite 400 North Charleston South Carolina 29405 (Address of principal executive offices) (Zip code) Registrant’s telephone number, including area code: 843 - 740-2300 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   ☐ Emerging growth company   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐   Item 1.01. Entry into a Material Definitive Agreement.   On March 30, 2025, Ingevity Corporation (the “ Company ”) entered into a cooperation agreement (the “ Cooperation Agreement ”) with Vision One Fund, LP and certain of its affiliates (the “ Vision One Parties ”).   Pursuant to the Cooperation Agreement, the Company agreed to (i) appoint F. David Segal to the Company’s Board of Directors (the “ Board ”) within one day of the 2025 annual meeting of stockholders (the “ 2025 Annual Meeting ”), (ii) appoint Mr. Segal to the Audit Committee of the Board and (iii) not increase the size of the Board to more than eleven directors until the earliest date pursuant to which stockholder nominations for dir

View on Read The Filing